+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Immunotherapy"

Anti-CD40 Antibody - Pipeline Insight, 2024 - Product Thumbnail Image

Anti-CD40 Antibody - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
From
US Alopecia Areata - Market Insight, Epidemiology And Market Forecast - 2032 - Product Thumbnail Image

US Alopecia Areata - Market Insight, Epidemiology And Market Forecast - 2032

  • Report
  • November 2023
  • 115 Pages
  • United States
From
From
Monoclonal antibodies - Competitive landscape, 2023 - Product Thumbnail Image

Monoclonal antibodies - Competitive landscape, 2023

  • Report
  • May 2023
  • 450 Pages
  • Global
From
CTLA-4 inhibitors- Competitive landscape, 2023 - Product Thumbnail Image

CTLA-4 inhibitors- Competitive landscape, 2023

  • Report
  • May 2023
  • 220 Pages
  • Global
From
Bispecific antibody - Competitive landscape, 2023 - Product Thumbnail Image

Bispecific antibody - Competitive landscape, 2023

  • Report
  • May 2023
  • 450 Pages
  • Global
From
From
Oncolytic Virus Cancer Therapy - Epidemiology Forecast - 2032 - Product Thumbnail Image

Oncolytic Virus Cancer Therapy - Epidemiology Forecast - 2032

  • Report
  • September 2022
  • 160 Pages
  • Global
From
Intratumoral Cancer Therapies - Epidemiology Forecast - 2032 - Product Thumbnail Image

Intratumoral Cancer Therapies - Epidemiology Forecast - 2032

  • Report
  • September 2022
  • 144 Pages
  • Global
From
From
Head and Neck Cancer (HNC) - Epidemiology Forecast - 2032 - Product Thumbnail Image

Head and Neck Cancer (HNC) - Epidemiology Forecast - 2032

  • Report
  • September 2022
  • 116 Pages
  • Global
From
Cytokine Release Syndrome (CRS) - Epidemiology Forecast - 2032 - Product Thumbnail Image

Cytokine Release Syndrome (CRS) - Epidemiology Forecast - 2032

  • Report
  • September 2022
  • 141 Pages
  • Global
From
From
Global Esophageal Squamous Cell Carcinoma - Pipeline Insight, 2022 - Product Thumbnail Image

Global Esophageal Squamous Cell Carcinoma - Pipeline Insight, 2022

  • Clinical Trials
  • August 2022
  • 150 Pages
  • Global
From
ATEZOLIZUMAB - Emerging Insight and Market Forecast - 2030 - Product Thumbnail Image

ATEZOLIZUMAB - Emerging Insight and Market Forecast - 2030

  • Report
  • February 2021
  • 50 Pages
  • Global
From
From
Nasopharyngeal Cancer Market Report and Forecast 2024-2032 - Product Thumbnail Image

Nasopharyngeal Cancer Market Report and Forecast 2024-2032

  • Report
  • February 2024
  • 180 Pages
  • Global
From
Synovial Sarcoma Market Report and Forecast 2024-2032 - Product Thumbnail Image

Synovial Sarcoma Market Report and Forecast 2024-2032

  • Report
  • February 2024
  • 180 Pages
  • Global
From
Loading Indicator

Immunotherapy is a type of treatment used to treat immune disorders, such as allergies, asthma, and autoimmune diseases. It works by stimulating the body's own immune system to fight off disease-causing agents. Immunotherapy drugs are designed to target specific parts of the immune system, such as T-cells, B-cells, and cytokines. These drugs can be used to treat a variety of conditions, including cancer, HIV/AIDS, and rheumatoid arthritis. Immunotherapy drugs are typically administered through injections, infusions, or oral medications. They can also be used in combination with other treatments, such as chemotherapy or radiation therapy. The goal of immunotherapy is to reduce the severity of symptoms and improve the patient's quality of life. The immunotherapy market is a rapidly growing sector of the pharmaceutical industry. Companies in this market are focused on developing new treatments and therapies to treat immune disorders. Some of the major players in this market include AbbVie, AstraZeneca, Bristol-Myers Squibb, GlaxoSmithKline, Merck, Novartis, and Pfizer. Show Less Read more